Trump's New Tariffs Impact India: Generic Drugs Exempt, Metals Face Changes, Negotiations Ongoing

Good afternoon listeners. Welcome back to India Tariff News and Tracker. I'm bringing you the latest developments in US trade policy that directly impact India and Indian businesses. Just yesterday, President Trump signed a sweeping executive order reshaping American tariff strategy across multiple sectors. While the administration has focused heavily on pharmaceuticals and metals, India finds itself in a complex position within this new trade landscape. According to the Trump administration's tariff tracker updated through April 2nd, India currently faces reciprocal tariffs that have been modified multiple times since the broader tariff regime took effect. The administration has issued several executive orders specifically addressing India tariffs, adjusting rates as negotiations continue between Washington and New Delhi. The pharmaceutical sector presents particular interest for Indian exporters, as India is a major supplier of generic drugs to the United States. The new proclamation imposes up to a 100 percent tariff on patented pharmaceuticals from companies that don't strike deals with the administration. However, generic pharmaceuticals and biosimilars are explicitly exempt from these tariffs at this time, with reassessment planned in one year. This exemption provides significant relief for India's robust generic drug industry. On the metals front, Trump's updated steel, aluminum, and copper tariffs took effect starting Monday with new calculation methods based on full customs value. These changes could affect Indian metal exports and derivative products shipped to American markets. What's particularly noteworthy is that the Trump administration has already secured trade agreements with more than twenty major trading partners, covering over half of global GDP according to White House statements. While India isn't specifically mentioned among the countries that have reached formal trade frameworks comparable to those with the EU, Japan, Korea, and Switzerland, the administration continues active negotiations. The US goods trade deficit has fallen 24 percent from April 2025 through February 2026, according to White House data. The administration credits its tariff strategy with rebalancing global trade relationships. For India specifically, these shifting dynamics mean ongoing uncertainty but also potential opportunities for businesses willing to navigate the new regulatory environment. Indian exporters should closely monitor whether their sectors receive preferential treatment or carve-outs in coming months. The 180-day negotiation window the administration mentioned for smaller companies and new deals suggests there's still time for India to secure more favorable terms in specific product categories. As always, listeners, stay tuned to this space for updates as these trade negotiations develop. Thank you for tuning in to India Tariff News and Tracker. Please don't forget to subscribe for the latest updates on how American tariff pol This content was created in partnership and with the help of Artificial Intelligence AI.